4-Methyl-2-(morpholin-4-yl)pyrimidine-5-carboxylic acid

Catalog No. :
ACNTRD652
CAS No. :
873450-22-7
Molecular Formula :
C10H13N3O3
Molecular Weight :
223.23

IUPAC Name:4-methyl-2-morpholinopyrimidine-5-carboxylic acid

4-Methyl-2-(morpholin-4-yl)pyrimidine-5-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$64.00Login to see priceInquiryInquiry
100mg95%$88.00Login to see priceInquiryInquiry
250mg95%$117.00Login to see priceInquiryInquiry
1g95%$217.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-2-(morpholin-4-yl)pyrimidine-5-carboxylic acid
IUPAC Name4-methyl-2-morpholinopyrimidine-5-carboxylic acid
Molecular FormulaC10H13N3O3
Molecular Weight223.23
SMILESO=C(C1=CN=C(N2CCOCC2)N=C1C)O
InChI KeyPGIPXUSYFVXCJQ-UHFFFAOYSA-N
Synonym4-METHYL-2-(4-MORPHOLINYL)-5-PYRIMIDINECARBOXYLIC ACID;4-METHYL-2-MORPHOLIN-4-YL-PYRIMIDINE-5-CARBOXYLIC ACID;5-PYRIMIDINECARBOXYLIC ACID, 4-METHYL-2-(4-MORPHOLINYL)-;AKOS VGYB0001116;OTAVA-BB 1086791;4-methyl-2-morpholinopyrimidine-5-carboxylic acid
CAS No.873450-22-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNTRD652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNTRD652 route product structure diagram
    ACNTRD652873450-22-7
Inquiry

2. ACNTRD652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNTRD652 route product structure diagram
    ACNTRD652873450-22-7
Inquiry

Comments (0)